Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie Milstien

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|October 2, 2003
Emergency response vaccines: lessons learned in response to communicable diseasesJulie Milstien
Bulletin of the World Health Organization|May 20, 2006
Managing the effect of TRIPS on availability of priority vaccinesJulie Milstien, Miloud Kaddar
Bulletin of the World Health Organization|March 26, 2004
Regulatory pathways for vaccines for developing countriesJulie Milstien, Lahouari Belgharbi
Expert Review of Vaccines|May 29, 2014
Tools and approaches to ensure quality of vaccines throughout the cold chainUmit Kartoglu, Julie Milstien
Vaccine|November 22, 2002
Emergency response vaccines--a challenge for the public sector and the vaccine industryJulie Milstien, Scott Lambert
Bulletin of the World Health Organization|June 19, 2014
Impact of BRICS' investment in vaccine development on the global vaccine marketMiloud Kaddar, Julie Milstien, Sarah Schmitt
Vaccine|March 18, 2003
Issues in selection of DTwP-based combination vaccinesJulie Milstien, Syarifah Liza Munira, Susan Loretan McKinney
Expert Review of Vaccines|April 29, 2009
Reaching international GMP standards for vaccine production: challenges for developing countriesJulie Milstien, Alejandro Costa, Suresh Jadhav, et al.
Vaccine|April 20, 2013
Global support for new vaccine implementation in middle-income countriesMiloud Kaddar, Sarah Schmitt, Marty Makinen, et al.
Malaria Journal|June 26, 2010
WHO policy development processes for a new vaccine: case study of malaria vaccinesJulie Milstien, Vicky Cárdenas, James Cheyne, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|October 2, 2003
Emergency response vaccines: lessons learned in response to communicable diseasesJulie Milstien
Bulletin of the World Health Organization|May 20, 2006
Managing the effect of TRIPS on availability of priority vaccinesJulie Milstien, Miloud Kaddar
Bulletin of the World Health Organization|March 26, 2004
Regulatory pathways for vaccines for developing countriesJulie Milstien, Lahouari Belgharbi
Expert Review of Vaccines|May 29, 2014
Tools and approaches to ensure quality of vaccines throughout the cold chainUmit Kartoglu, Julie Milstien
Vaccine|November 22, 2002
Emergency response vaccines--a challenge for the public sector and the vaccine industryJulie Milstien, Scott Lambert
Bulletin of the World Health Organization|June 19, 2014
Impact of BRICS' investment in vaccine development on the global vaccine marketMiloud Kaddar, Julie Milstien, Sarah Schmitt
Vaccine|March 18, 2003
Issues in selection of DTwP-based combination vaccinesJulie Milstien, Syarifah Liza Munira, Susan Loretan McKinney
Expert Review of Vaccines|April 29, 2009
Reaching international GMP standards for vaccine production: challenges for developing countriesJulie Milstien, Alejandro Costa, Suresh Jadhav, et al.
Vaccine|April 20, 2013
Global support for new vaccine implementation in middle-income countriesMiloud Kaddar, Sarah Schmitt, Marty Makinen, et al.
Malaria Journal|June 26, 2010
WHO policy development processes for a new vaccine: case study of malaria vaccinesJulie Milstien, Vicky Cárdenas, James Cheyne, et al.
Pageof 2